Our news

  • Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. Here you will find a continued update of Cochrane’s activities in response to the coronavirus (COVID-19) pandemic.For more information, visit the Cochrane Website Cochrane published:8 Special Collections 32 New and updated...
    April 8 2021
  • The Cochran Skin group published the updated review -Systemic pharmacological treatments for chronic plaque psoriasis-Psoriasis is an immune-mediated skin disease, which has a major impact on quality of life of the patients affected. The aim of this review was to compare different systemic medicines used to treat psoriasis and to find the...
    April 8 2021
  • The updated versions of two Cochrane reviews were recently published by the review group Cochrane Pregnancy and Childbirth. They concern the efficacy of a single dose of one of these two drugs for relieving perineal pain that many women experience soon after giving birth:·         Paracetamol/acetaminophen (...
    March 2 2021
  • A newly published editorial in the Cochrane Library addresses how Cochrane has responded to the COVID-19 pandemic, what the limitations to COVID-19 evidence are, and suggestions on how policy makers can move forward with best available evidence. The urgency to define the relevant knowledge base in preventing, diagnosing, and managing COVID-19 and...
    November 30 2020
  • Cochrane defines knowledge translation (KT) as the process of supporting the use of health evidence by those who need to make health decisions. This module aims to strengthen the understanding of what KT means within Cochrane. It presents information, examples, and stories told by characters in order to explain the concepts of KT. It is free...
    October 20 2020
  • When children have an asthma attack, the standard treatment, called “first-line treatment”, is mostly steroids to reduce the inflammation and swelling and inhaled medications to relax the muscles in the air passages. Some children do not improve and a “second-line treatment” is necessary – usually at the emergency department or in the hospital....
    September 22 2020
  • Cochrane has started an international survey about what type of COVID-19 evidence is most useful for scientists, health professionals and the general public: What types of COVID-19 evidence are influencing your decisions? Where do you get your COVID-19 information from? What are the types and formats of evidence you need most?Please help us...
    September 3 2020
  • You are interested in health topics; you are a patient, health care professional, or journalist? Please help us to improve Cochrane evidence! We want to find out how people understand the Plain Language Summaries of our systematic reviews and how we can improve them. You can help us: We are looking for volunteers to read two summaries and to...
    September 1 2020
  • Do psychological interventions designed to foster resilience improve resilience, mental health and other factors associated with resilience in healthcare professionals?This question is particularly relevant at the moment, when healthcare workers are under great pressure due to COVID-19. The work of healthcare professionals can be very stressful...
    July 31 2020
  • Cochrane Rehabilitation REH-COVER (Rehabilitation – COVID-19 Evidence-based Response action COVID-19Rehabilitation is a multiprofessional process aimed at enhancing and restoring functional ability and quality of life to people with impairments or disabilities. In the context of the COVID-19 pandemic, rehabilitation focuses on the sequelae of...
    July 27 2020

Pagine

Subscribe to Our news